EU Court Revives Glaxo Dual Pricing Case
Giving heart to the pharmaceutical industry, the European Union's highest court has ordered regulators to reconsider whether GlaxoSmithKline PLC should be exempted from antitrust law and allowed to raise prices against...To view the full article, register now.
Already a subscriber? Click here to view full article